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BACKGROUND: The influence of the stromal microenvironment on the progression of epithelial cancers has been demonstrated.
Unravelling the mechanisms by which stromal cells affect epithelial behaviour will contribute in understanding cellular malignancy.
It has been proposed that redox environment has a role in the acquisition of malignancy. In this work, we studied the influence
of epithelial cells on the stromal redox status and the consequence of this phenomenon on MCF-7 cell motility.
METHODS: We analysed in a co-culture system, the effect of RMF-EG mammary stromal cells on the migratory capacity of MCF-7 cell
line. To test whether the NOX-dependent stromal redox environment influences the epithelial migratory behaviour, we knocked
down the expression of NOX4 using siRNA strategy. The effect of TGF-b1 on NOX4 expression and activity was analysed by qPCR,
and intracellular ROS production was measured by a fluorescent method.
RESULTS: Migration of MCF-7 breast epithelial cells was stimulated when co-cultured with RMF-EG cells. This effect depends on
stromal NOX4 expression that, in turn, is enhanced by epithelial soluble factors. Pre-treatment of stromal cells with TGF-b1
enhanced this migratory stimulus by elevating NOX4 expression and intracellular ROS production. TGF-b1 seems to be a major
component of the epithelial soluble factors that stimulate NOX4 expression.
CONCLUSIONS: Our results have identified that an increased stromal oxidative status, mainly provided by an elevated NOX4
expression, is a permissive element in the acquisition of epithelial migratory properties. The capacity of stromal cells to modify their
intracellular ROS production, and accordingly, to increase epithelial motility, seems to depend on epithelial soluble factors among
which TGF-b1 have a decisive role.
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Convincing experimental data support the involvement of cellular
stroma in carcinoma progression (De Wever and Mareel, 2003).
Particularly, there is strong evidence supporting the role of the
stromal cells in breast cancer growth and development (Radisky
and Radisky, 2007). Available data suggest that carcinoma and
stromal cells maintain an active dialogue with functionally
reciprocal consequences. In that way, soluble stromal products
are able to modify the invasive potential of carcinoma cells, and
epithelial factors are responsible for the development of a ‘stromal
response’ that in some tumours, such as those of breast, stomach
and pancreas, is termed desmoplasia (Elenbaas and Weinberg,
2001).
Among the variety of cell types that constitute the tumoral
microenvironment, fibroblasts have been mentioned as an impor-
tant component. Under the stimuli of tumour cells, fibroblasts are
able to acquire some functional properties that confer them a
‘reactive’ phenotype, becoming what is termed as carcinoma-
associated fibroblasts (CAFs) (Egeblad et al, 2005). Considerable
experimental work sustains that CAFs produce tumour-promoting
and angiogenic factors along with chemokines that contribute to
the recruitment of bone marrow-derived cells (Ostman and
Augsten, 2009).
An emerging issue in the carcinogenesis field has arisen from
studies that revealed that a chronic inflammatory condition
predisposes the epithelial component of tissues to develop a
tumour (Coussens and Werb, 2002). A key element in this process
is the establishment of an oxidative stress at the tissue level that
generates an increase in reactive oxygen species (ROS) pheno-
menon that, as has been previously demonstrated, contributes to
carcinoma malignancy (Blanchetot and Boonstra, 2008). Some
previous observations indicate that ROS, acting as secondary
messengers, have a role in the regulation of cell proliferation,
which is crucial in tumour cells that produce elevated ROS levels
(Szatrowski and Nathan, 1991).
The cellular oxidative stress that contributes to the aetiology of
cancer is produced by an endogenous generation of ROS that
arises from two main sources: the mitochondria and the NAD(P)H
oxidase (NOX) system (Dro ¨ge, 2002). In non-phagocytic cells, the
NOX family is a key component of the so-called ‘redox signalling
system’ that regulates many cellular responses by modulating the
intracellular ROS content. The alteration in the cellular oxidative
status generates changes in processes such as cell migration and
growth (Ushio-Fukai and Nakamura, 2008). For example, it has
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sbeen demonstrated that the NOX-dependent basal oxidative stress
of both prostatic cell lines and normal epithelial cells is directly
associated with the expression of the aggressive phenotype
(Kumar et al, 2008). On the other hand, it has also been
demonstrated that NOX1 stimulates cell proliferation, activating
the cell cycle by reducing the requirement for growth factors
to maintain the expression of cyclin D1 and stimulating
the transcriptional activation of Fos family genes during the
immediate early gene response (Ranjan et al, 2006).
In this study we investigate the influence that a human
mammary fibroblast cell line (RMF-EG cells) exerts on the
migratory behaviour of the weakly invasive human mammary cell
line MCF-7. Using a co-culture system as a model of stromal–
epithelial interaction, we analysed the role of the NOX-dependent
oxidative intracellular status of RMF-EG cells on the migration of
MCF-7 cells. In addition, we studied the role of TGF-b1, a growth
factor that is highly expressed in tumour cells, in the maintenance
of a pro-oxidative environment and the consequent production of
soluble factors that stimulate epithelial migration.
MATERIALS AND METHODS
Chemicals reagents
Human recombinant TGFb1 was purchased from R&D Systems
(Minneapolis, MN, USA). 20,70-dichlorodihydrofluorescein diace-
tate (H2DCFDA), N-acetylcysteine (NAC), diphenyleneiodonium
chloride (DPI) and bovine catalase were from Sigma (St Louis, MO,
USA). SB431542 inhibitor was from TOCRIS Bioscience (Business
Park Ellisville, MO, USA).
Cell culture and transfection methods
Human mammary cell lines MCF-7, MCF-10 and MDA MB-231
were obtained from the ATCC (Manassas, VA, USA) and were
cultured in DMEM/F12 medium (Invitrogen, Carlsbad, CA, USA)
supplemented with 10% fetal bovine serum (FBS) (Hyclone, Logan,
UT, USA) and maintained in a humidified atmosphere of 371C, 5%
CO2. RMF-EG stromal cells were kindly provided by Dr Charlotte
Kuperwasser (Tufts University, Boston, MA, USA) and cultured in
DMEM medium (Invitrogen) supplemented with 10% FBS
(Kuperwasser et al, 2004). MCF7 cells were transiently transfected
with 2mgml
–1of the plasmid encoding for the dominant-negative
form of TGF-b receptor I (dnTbRI) or pcDNA3.1 (empty vector),
using Lipofectamine 2000 reagent according to the manufacturer’s
protocol (Invitrogen). The 48h post-transfected cells were used to
stimulate migration of MCF-7 cells.
Cell migration assay
MCF-7 and MCF-10 cell migration was studied using a 6.5-mm
Transwell chamber with a pore size of 8mm (Corning, Corning,
NY, USA). The Transwell membranes were coated with 10% FBS in
culture media for 2h at 371C only on the underside. MCF-7 and
MCF-10 cells (6 10
4) were re-suspended in serum-free medium
and seeded on the upper compartment of the chamber. RMF-EG
cells that were untreated or pre-treated with DPI or NAC were used
to induce migration of MCF-7 cells. For this, 4 10
4 RMF-EG cells,
suspended in culture media enriched with 1% FBS, were incubated
with 5mM of DPI or 1mM NAC for 16h and were then washed with
1  PBS twice, before placing the insert with migrating MCF-7
cells. Additionally, we evaluated the migratory ability of MCF-7
cells that were stimulated by RMF-EG cells pre-treated 16h with
10ngml
–1 of TGF-b1 in the presence or absence of 5mM of DPI
(added 30min before) and RMF-EG cells transfected with the
dominant-negative version of dnTbRI. In this case, the lower
chamber of the Transwell was filled with medium enriched with
1% FBS. Migration was allowed to occur for 24h, after which cells
of the upper membrane surface were removed by a cotton swab
and repeatedly washed with PBS. In migration experiments
performed in the presence of catalase, 3000IU of bovine catalase
(Sigma) was added to the lower chamber of the Transwell.
Migration values were determined by counting five ( 20) fields
per chamber after fixing the membrane in methanol and staining
the migratory cells on the lower side of the membrane with 0.2%
crystal violet (Tobar et al, 2008).
Co-culture in non-migrating conditions
We also performed Transwell experiments using a 0.4-mm pore
membrane (24mm diameter) bicameral system that prevents cell
migration. RMF-EG cells (5 10
5) were cultured in the lower well
and MCF-7 cells (5 10
5) in the upper chamber of the Transwell in
serum-free media for 24h. Both cell types were lysed with TRIzol
to extract RNA.
Knockdown assays
For transient siRNA transfection, RMF-EG cells at 70% confluence
were transfected using TransIT-siQuest (Mirus, Madison, WI,
USA) at 1:600 dilutions in complete medium, according to the
manufacturer’s recommendation, with a final siRNA concentration
of 50nM for 72h. The oligos used to inhibit NOX4 expression were
obtained from Santa Cruz (sc-41586, Santa Cruz, CA, USA), which
is referred in the text as siRNA NOX4-I, and from Integrated DNA
Technologies (Coralville, IA, USA) with the following sequences:
50-GCCUCUACAUAUGCAAUAA-30 and is referred to as NOX4-II
(Carmona-Cuenca et al, 2008). As a control unsilenced siRNA, the
sc 37007 oligo from Santa Cruz was used.
Measurement of intracellular redox state
The oxidation-sensitive fluorescent probe H2DCFDA was used to
analyse the total intracellular content of ROS. In a representative
assay, RMF-EG cells were incubated with 5.0mM H2DCFDA in
serum- and phenol red-free medium (Gibco Invitrogene, Carlsbad,
CA, USA) for 30min at 371C. Cells were then washed and lysed
with 0.1N NaOH, and fluorescence was monitored using
a microplate fluorometer (Spectra MAX, Gemini EM; Molecular
Devices, Silicon Valley, CA, USA) with wavelengths of 480 and
530nm for excitation and emission, respectively (Benhar et al,
2001). In experiments in which NOX-dependent ROS production
was blocked, cells were transfected with NOX4 siRNA 72h
previous to ROS determination. In experiments in which the
intracellular content of ROS was exogenously modulated, RMF-EG
cells were pre-treated 24h with 1–10ngml
–1 of TGF-b1 before
fluorometric determination of ROS.
Immunodetection of NOX4
Serum-starved RMF-EG cells (10
6 cells per dish) were treated with
TGF-b1 (1–10ngml
–1) for 24h or transfected with siRNA for
NOX4. Afterwards, total protein extracts were obtained using a
lysis buffer containing 30mM Tris-HCl pH 7.5, 5.0mM EDTA,
150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycolate, 0.1%
SDS and 10% glycerol, 2mM PMSF, 2mgml
–1 pepstatin, 2mgml
–1
leupeptin and 1mM orthovanadate at 41C. Pellets were incubated
for 1h in lysis buffer at 41C, sonicated for 5s, boiled for 5min and
centrifuged at 16500g for 10min at 41C. The antibodies used were:
mouse anti-b-actin (clone AC-15; Sigma) and anti-NOX4 rabbit
polyclonal antibody (ab 41886; Abcam, Cambridge, MA, USA).
Equal amounts of protein from different treatments were resolved
by 10% SDS–PAGE and analysed by immunoblotting using the
ECL chemiluminiscence detection kit (Amersham, Arlington
Heights, FL, USA).
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Total RNA was isolated with Trizol (GIBCO, Carlsbad, CA, USA)
from RMF-EG and control cells. Complementary DNA was
generated by M-MLV reverse transcriptase (Promega, Madison,
WI, USA) using oligo (dT) (Promega) as primer and 1.5mg of total
RNA. Semiquantitative PCR reactions were performed using the
following human-specific primers:
NOX1, forward 50-GTACAAATTCCAGTGTGCAGACCAC-30 and
reverse 50-CAGACTGGAATATCGGTGACAGCA-30, PCR product
size 397 and 250bp, corresponding to the large and short forms of
the molecule; NOX2, forward 50-GTCACACCCTTCGCATCCATTC
TCAAGTCAGT-30 and reverse 50CTGAGACTCATCCCAGCCAGTG
AGGTAG-30, PCR product size 225bp; NOX4, forward 50-TAGATA
CCCACCCTCCC-30 and reverse 50-GACTTATGACCGAAATGA-30,
PCR product size 294bp; NOX5, forward 50-ATCAAGCGGCCCCC
TTTTTTCAC-30 and reverse 50-CTCATTGTCACACTCCTCGACA
GC-30, PCR product size 239bp; a-Sma, forward 50-GCAGCCCAG
CCAAGCACTGTCAGGAAT-30 and reverse 50-AGCCCAGAGCCAT
TGTCACACACCAAGG-30, PCR product size 674bp; QNOX4,
forward 50-TAGATACCCACCCTCCCG-30 and reverse 50-TGGGCT
CTTCCATACAAATC-30, QPCR product size: 168bp; 18S, forward
50-GGACACGGACAGGATTGACA-30 and reverse 50-GGACATCTA
AGGGCATCACAG-30, PCR product size 240bp.
The expression of 18S was analysed as a loading control. PCR
products were subjected to electrophoresis on a 1.5% agarose
gel, and DNA was visualised by ethidium bromide staining.
Quantification of bands was determined using KODAK Molecular
Imaging Software Version Upgrade 4.0 (Kodak, Rochester, NY,
USA). To identify the expression of the different isoforms of NOX
in RMF-EG cells, RT–PCR was run for 38 cycles. To test the effect
of epithelial factors on NOX4 and NOX5 expression in co-culture,
RT–PCR was performed at the linear zone of the saturation curve,
that is, 32 cycles for both isoforms.
Quantitative PCR was performed with the real-time PCR system,
LightCycler (Roche, Basel, Switzerland). Each reaction was conducted
in glass capillaries with 50ng of cDNA, in a final volume of 10ml. The
PCR mixture contained LC FastStart DNA Master SYBR Green I
(Roche Diagnostics, Basel, Switzerland), 3mM MgCl2 and 0.3pmol of
each primer (forward and reverse). Fluorescence was analysed using
LightCycler Analysis Software. The crossing point for each reaction
was determined using the Fit point algorithm and manual baseline
adjustment. Quantification was determined using a relative standard
curve method with different amounts of a reference standard DNA
generated from PCR amplicon for each target gene and expressed as
copies per ml. The template for the gene-specific standard curve was
generated via conventional PCR and purification was performed
using a Concert Rapid Gel extraction system (Gibco Invitrogene). The
amount of transcript for each gene of interest was normalised against
the 18S transcripts. The experiments were performed three times and
in duplicate from three different RNA samples.
RESULTS
Co-culture of MCF-7 cells with RMF-EG stromal cells
enhanced their migratory activity: a possible role for NOX
To evaluate the inductive role of RMF-EG mammary stromal cells
on MCF-7 migration, we established an 8-mm pore size Transwell
system, plating 4 10
4 RMF-EG cells in the lower chamber surface
and 6 10
4 MCF-7 in the insert, according to the protocol
described in the Materials and Methods. To analyse the involve-
ment of stromal NOX-dependent ROS production on MCF-7 cells
migration, we pre-incubated RMF-EG monolayer overnight with
5mM of the flavoprotein inhibitor DPI. To analyse the participation
of ROS, independent of its intracellular source, we pre-incubated
another group of RMF-EG stromal cells with 1mM NAC, a potent
antioxidant molecule with a broad spectrum of action. After this,
cells were washed and the insert containing MCF-7 cells was
installed, thus initiating the migration assay. As Figure 1A shows,
co-culture of epithelial cells with intact stromal cells induced a
three-fold increase in cell migration. Pre-treatment of RMF-EG
cells with DPI or NAC abrogated this effect almost completely.
To assess the specificity of the stromal effect on tumour cells, we
performed a migratory assay in the same experimental conditions
described above, but using the MCF-10 cell line, a non-tumour
homologue of MCF-7 cells line. As Figure 1A shows, migration of
MCF-10 cells was not modified by co-culture conditions or the
presence of stromal cells that were pre-treated with antioxidant
molecules. From the results on MCF-7 cells, two possible expla-
nations arise: on one hand, under the stimulus of soluble epithelial
factors, RMF-EG cells generate a soluble form of ROS that
stimulates migration of MCF-7 cells and , on the other hand, the
epithelial-induced changes in stromal redox status induces the
expression of an unknown soluble factor that modulates MCF-7
migration. To evaluate these two possibilities, we performed
migration assays in which 3000IU of bovine catalase was included in
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Figure 1 Mammary stromal cell line RMF-EG stimulates MCF-7 cell line migration. A possible role for ROS. (A) Co-culture system of epithelial and
mammary stromal cells. RMF-EG (4 10
4), MCF-7 (6 10
4) and MCF-10 (6 10
4) cells were seeded separately in the lower well and upper chamber,
respectively, of a Transwell culture system. A group of RMF-EG cells were pre-treated for 16h with 5mM diphenyleneiodonium chloride (DPI) or 1mM NAC
and washed before the introduction of the insert containing MCF-7 cells. (B) In the same experimental setting, migration of MCF-7 cells was evaluated in the
presence or the absence of 3000IU of catalase diluted in the lower compartment of the Transwell. Migration was evaluated after 24h of co-culture by
counting stained migrating cells on the lower side of the filter, as indicated in the Materials and Methods. Data represent the mean±s.e. of four independent
experiments. Student’s t-test was used to compare MCF-7 migrating cells co-cultured with RMF-EG vs control non-co-cultured cells and MCF-7 migrating
cells co-cultured with DPI-pretreated RMF-EG cells. *Po0.05, **Po0.01.
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sthe lower well of the Transwell. As Figure 1B shows, either in
the presence or in the absence of RMF-EG cells, exogenous
catalase does not affect the basal or the stimulated MCF-7 migration,
suggesting that the generation of a redox-dependent migratory
soluble factor from RMF-EG origin is the more plausible possibility.
Expression of mRNA for NOX4 in stromal cells
is stimulated by co-culture with MCF-7 cells
The ability of DPI to inhibit the RMF-EG-dependent MCF-7 cell
migration strongly suggests that some of the isoforms described
for NOX in these stromal cells were having a role is this paracrine
stimulus. Therefore, using specific primers, we analysed which
isoforms of the NOX system are expressed in RMF-EG cells.
RT–PCR analysis of mRNA extracted from these cells shows
that they expressed predominantly the NOX4 and NOX5 isoforms
(Figure 2A). As a primer control, mRNAs from different cell lines
that express specific NOX were used. NOX3 was not included in
this analysis because it has been demonstrated that it is expressed
mainly in fetal tissues (Cheng et al, 2001).
Once we identified that NOX4 and NOX5 were the predominant
isoforms for NOX in RMF-EG cells, we analysed whether the
expression of mRNA for these isoforms was modified by soluble
factors generated by MCF-7 cells. To test this, RMF-EG cells
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Figure 2 Soluble factors produced by MCF-7 cells induced the expression of NOX4 isoforms in RMF-EG cells. (A) The analysis of the expression of
NOX family components in RMF-EG cells was performed by RT–PCR, as described in the Materials and Methods. Total RNA was prepared using TRIzol
reagent and RT–PCR was performed using specific primers for human NOX 1, 2, 4 and 5 isoforms. PCR products were compared with those from an equal
amount of mRNA from cell lines that express the different forms of NOX as CaCo cells (for NOX1), U266 (for NOX2), MDA 231 (for NOX4) and
DU145 (for NOX5). All isoforms were analysed at 38 cycles. (B) Using a bicameral co-culture system similar to those used in experiments in Figure 1, with a
membrane pore of 0.4mm to avoid cell migration, we cultured RMF-EG cells (in the lower well) and MCF-7 cells in the upper chamber of the Transwell
system for 24h in FBS-free culture medium. NOX4, NOX5 and a-Sma mRNA expression in RMF-EG cells were measured in a TRIzol-generated total
mRNA solution as described in the Materials and Methods. NOX4 and NOX5 were analysed at 32 cycles and a-Sma at 24 cycles. Data in (C) represent the
mean±s.e. of densitometric analysis of three different experiments. Student’s t-test was used to compare control non-co-cultured cells vs co-cultured cells.
*Po0.05.
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cell migration) and co-cultured for the same period used in the
migratory assay (24h). In addition, to assess if the contact
with mammary cell-produced factors constitutes a stimulus for
myofibroblast differentiation, we analysed in RMF-EG cells the
expression of a-Sma, a distinctive marker of this phenotype.
As Figure 2B and C shows, RMF-EG cells co-cultured with MCF-7
mammary cells express almost four-fold NOX4 mRNA compared
with untreated cells. The MCF-7 stimulus enhanced two-fold
the a-Sma expression, suggesting that the postulated epithelial
soluble factors may also constitute a stimulus for myofibroblast
differentiation. No stimulatory effect was observed in the case
of NOX5.
Targeted NOX4 knockdown with a specific siRNA blocks
RMF-EG stimulus on MCF-7 migration
To study the possible role of NOX4 in the RMF-EG-mediated
stimulus on MCF-7 migration, we used a targeted knockdown
by siRNA approach to downregulate the enzyme expression.
As Figure 3A shows, RMF-EG cells transiently transfected with
siNOX4 were unable to generate a migratory stimulus on MCF-7
cells. We also detected that NOX4 knockdown cells expressed
lower levels of NOX4 at the protein level (measured by western
blot) and a diminished capacity to generate intracellular ROS
(Figure 3B and C).
Pre-treatment of RMF-EG stromal cells with TGF-b1
stimulates cell migration on MCF-7 cells
Searching for a specific factor that regulates the RMF-EG-mediated
stimulus on MCF-7 migration, we tested whether TGF-b1, a growth
factor implicated in the control and expression of NOX in
some cells (Murillo et al, 2007), was able to modulate the NOX4-
dependent stimulus of RMF-EG cells. To test this hypothesis,
RMF-EG cells were stimulated overnight with TGF-b1 (10ngml
–1),
previous to the onset of the cell migration assay. As Figure 4
shows, TGF-b1 pre-treated RMF-EG cells exhibit almost double
effectiveness to stimulate MCF-7 migration. To test if a NOX
activity is involved in the TGF-b1-dependent enhancement of
epithelial migration, we incubated RMF-EG cells with 5mM of DPI
30min before pre-treatment with TGF-b1. Figure 4 also shows
that DPI strongly inhibited TGF-b1 stimulus on MCF-7 migration.
It is important to note that neither TGF-b1 nor DPI were present
during the migration assay. Finally, to test if the signalling route
activated by the factor is implicated in this effect, we performed
a migratory assay using RMF-EG cells expressing a dominant-
negative version of the TbR1. As Figure 4 shows, these mutant cells
are unable to stimulate MCF-7 migration, indicating that the
integrity of the TGF-b1-dependent signalling route is a requisite
for the stimulus on MCF-7 migration.
TGF-b1 stimulates expression of NOX4 in RMF-EG
stromal cells
To analyse whether the effects of stromal NOX4 and TGF-b1
activity stimulating MCF-7 cell migration are functionally linked,
we studied the effect of TGF-b1 on NOX4 expression in RMF-EG
mammary stromal cells. To do this, we incubated RMF-EG cells
for 24h with different concentrations of TGF-b1 and evaluated
the NOX4 expression by real-time PCR. As shown in Figure 5A,
TGF-b1 exerts a dose-response stimulus on NOX4 mRNA
expression in the whole range of concentrations evaluated. The
same treatment induces a linear enhancement on NOX4 protein
and ROS production, evaluated by measuring the intracellular
ROS content by cell fluorescence after loading with DCDHF-DA
(Figure 5B and C).
TGF-b1 present in medium conditioned by mammary
tumoral cells is responsible for the expression of NOX4
To analyse whether TGF-b1, a component of the medium condi-
tioned by mammary cells, is responsible of the enhanced expres-
sion of NOX4 in RMF-EG cells, we stimulated NOX4 expression by
culturing stromal cells with medium conditioned (CM) by weakly
(MCF-7) and strongly invasive (MDA-MB 231) human mammary
cell lines that express and secrete a level of TGF-b1 proportional
with their invasive potential, as we have recently demonstrated
(Guerrero et al, 2010). To identify the contribution of TGF-b1
to NOX4 expression, we incubated RMF-EG cells in the presence
or the absence of SB431542, a potent inhibitor of TbRI kinase
activity that causes a blockage of Smad2/3 signalling route (Inman
et al, 2002). As is shown in Figure 6, the expression of NOX4
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Figure 3 NOX4-targeted knockdown RMF-EG cells do not induce
MCF-7 cell migration. Cells transfected with either unspecific siRNA
(siControl) or two different specific NOX4 siRNAs (SiNOX4 I and II) were
seeded in the lower well of a Transwell double chamber system as in
Figure 1 to stimulate MCF-7 cell migration. MCF-7 migration was evaluated
as described in the Materials and Methods (A). Immunoreactive NOX4
protein expression in transfected cells was evaluated by western blot (B).
Intracellular ROS production in siRNA- transfected cells was measured with
DCDHF-DA as indicated in the Materials and Methods (C). *Po0.05
**Po0.01.
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mammary cells in a magnitude that is proportional to its invasive
potential that, in turn, is directly proportional with their TGF-b1
content. SB431542 completely inhibited the stimulus of CMs,
suggesting that TGF-b1 is the major component of the soluble
factors generated by mammary cells that stimulate NOX4
expression.
DISCUSSION
Cancer is one of the recognised pathologies whose progression has
been associated with oxidative stress (Szatrowski and Nathan,
1991). The role of ROS in the initiation, promotion and
progression of cancer involves their effects on cell replication,
angiogenesis, apoptosis and migration (Halliwell, 2007). Previous
data from our group and others have emphasised the importance
of the redox balance in the acquisition of a malignant behaviour.
These findings confirm the importance of endogenous generation
of ROS by members of the NOX family and the regulatory role of
the small GTPase Rac 1 in the epithelial migration (Kumar et al,
2008; Tobar et al, 2008).
Extensive evidence has been generated underscoring the
relevance of the stroma in carcinogenesis (Radisky and Radisky,
2007). Recent data using a murine model highlight the importance
of the stromal component on mammary tumourigenesis. These
researchers have shown that Pten genetic ablation in mammary
stromal fibroblasts cause ECM remodelling, recruitment of innate
immune cells and an acceleration of the initiation, progression
and malignant transformation of mammary epithelial tumours
(Trimboli et al, 2009). In many other examples, tumour cells
induce the production of inflammatory mediators that generate a
chronic condition that supports the establishment of paracrine
signalling that stimulates epithelial tumoral progression (Spaeth
et al, 2008). Under this persistent inflammatory condition, it is
easily expected that the tissue redox balance will be affected mainly
by the production of ROS by non-epithelial cells under cancer cell
stimulus (Benz and Yau, 2008).
Our results suggest that, under the stimulus of soluble factors
secreted by MCF-7 mammary epithelial cells, RMF-EG mammary
stromal cells modulate their own oxidative status by increasing
the expression of NOX4, an enzymatic complex that has a relevant
signalling function in mammary cells (Mahadev et al, 2004).
Stromal NOX expression was able to stimulate the migratory
capacity of MCF-7 cells as we have demonstrated using the siRNA
strategy to knock down the expression of NOX4 (Figure 3A–C).
These results emphasise the importance of a redox threshold in
stromal cells needed to sustain a stimulus for epithelial cell
migration. It has been demonstrated that in non-phagocytic cells,
NOX4 is predominantly localised to the endoplasmic reticulum
where it regulates the activity of protein tyrosine phosphatase 1B
(Chen et al, 2008). We propose that, as a consequence of NOX4
activity, one (or several) signalling molecule(s) is generated by
stromal cells to modulate, in a paracrine manner, epithelial
migration. This property seems to be distinctive of tumoral cells
because the MCF-10 cell line, which represents a non-tumoral
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Figure 4 TGF-b1-pretreated RMF-EG cells display a greater effect on
MCF-7 migration. RMF-EG cells were pre-incubated or not with TGF-b1
(10ngml
–1) for 16h and seeded in the lower well of a Transwell double
chamber system as in Figure 1. A group of these factor-treated cells were
also incubated with 5mM diphenyleneiodonium chloride (DPI). Another
group of cells were transiently transfected with a dominant-negative version
of the type I receptor of TGF-b1( T bRI). These cell monolayers stimulated
for 24h the migration of MCF-7 cells seeded in the insert of the Transwell.
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Figure 5 TGF-b1 stimulates the expression of NOX4 in RMF-EG cells.
Stromal RMF-EG cells were grown until semiconfluence and deprived of
FBS overnight. After this, cells were treated with increasing concentrations
of TGF-b1 for 24h. Thereafter, a group of cells were used to analyse the
mRNA expression through qPCR (A), protein expression through western
blot (B) and intracellular ROS production measuring fluorescence
generated after H2DCFDA incubation according to the Materials and
Methods section (C). *Po0.05 **Po0.01.
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scounterpart of MCF-7 cell line, does not respond to the stromal
stimulus. Transwell migration experiments performed in MCF-7
cells in the presence of catalase allowed us to rule out the
participation of diffusible forms of ROS as part of the migratory
stimulus (Figure 1B).
In a previous work, we analysed by immunohistochemistry the
presence of TGF-b1 in samples of human ductal infiltrant
mammary tumours. We found that this factor, which had an
important role in the inhibition of the expression of adipogenic
transcription factors, was expressed only by tumoral cells located
at the invasive front, without a relevant expression in stromal
adipose cells (Guerrero et al, 2010). In our experimental model,
TGF-b1 exerts its pro-migratory stimulus through the stromal
compartment by a phenomenon that is abolished by pre-treatment
with DPI, that is, it depends on NOX activity (Figure 4). Besides
this NOX-mediated migration stimulated by TGF-b1, the results in
Figure 5 also show that NOX4 expression is induced by TGF-b1.
Therefore, TGF-b1 action in this co-culture system may be
explained by two simultaneous mechanisms: the NOX-dependent
production of a soluble factor that stimulates MCF-7 migration
and the enhancement of NOX4 expression by TGF-b1. Thus, the
generation of a stromal intracellular oxidative environment by
epithelial TGF-b1 can originate a positive feedback loop that
further stimulates the production of soluble factor(s) that favour
epithelial cell migration. This finding suggests a new mechanism
for tumoral malignancy that may complement the well-known
effect of epithelial oxidative environment in the acquisition of
cellular migratory capacity (Kumar et al, 2008). Furthermore,
stromal NOX4 seems to be a molecular target of TGF-b1 present
in media conditioned by breast carcinoma cell lines, as was
confirmed by the use of the TbRI inhibitor SB431542 that totally
abolished the expression of NOX4 stimulated by media condi-
tioned by MCF-7 and by MDA MB-231 cells, a more invasive cell
line that secretes four times more TGF-b1 than MCF-7 (Guerrero
et al, 2010).
TGF-b1 has been shown to increase the expression of NOX4
in different types of cells, although the localisation of NOX4 is
still under debate. In fetal rat hepatocytes, this growth factor
increased NOX4 expression as a part of a factor-induced apoptotic
programme (Murillo et al, 2007). Also, it has been identified that
ROS production in human hepatocyte cell lines previously infected
with hepatitis C virus depends on NOX4 activity whose expression
is, in turn, stimulated by TGF-b1 (Boudreau et al, 2009). More
recently, it has been demonstrated in murine fibroblasts that the
TGF-b1-stimulated expression of NOX4 results in the MAPK
phosphatase-1 (MKP-1) oxidation, which is directly responsible
for the factor-dependent modulation of gene expression (Liu et al,
2010). Our current effort is oriented to identify the specific
molecular target whose oxidative condition is modified by NOX4,
which would be responsible for the stromal stimulus to epithelial
migration.
Collectively, the results presented herein emphasise a role for
the stroma in the establishment of the patho-physiological
conditions that support epithelial malignancy. Our proposal
highlights the importance of the generation of an oxidative
tumoral environment that favours epithelial motility and con-
tributes, in this manner, to the expression of the malignant
phenotype. Stromal NOX4-derived ROS that has been implicated
in a variety of physiological processes (Brown and Griendling,
2009) may represent a potential target to prevent the acquisition
of malignant properties by the epithelial compartment.
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